Our Mission

Pioneering
Progress,
Powering
Possibilities

As the world pivots to tackle new challenges for a smarter, more sustainable future, New Life Biologics is proud to be at the frontier of this change. Using proprietary technology we turn biological products from concept to cutting-edge breakthroughs – working with the raw power of nature to leverage benefits for the people and the planet we share.

We produce and sell premium-grade plasma fractions and animal extract products tailored for applications for life science research, diagnostics, and biopharmaceuticals.

Led by industry leaders

Simon
Egan

President

Simon Egan is the President of New Life Biologics, where he plays a pivotal role in shaping the company's overall strategy, direction, and investor and supply strategies. With a rich background in the industry, Simon is a major shareholder, director, and former CEO of Greenlea Meats, a prominent New Zealand beef processor and exporter. He also co-founded BioArra, a US-based manufacturer specialising in high-value blood serum products for the scientific and pharmaceutical markets, which was acquired by VWR in 2016.

Furthermore, Simon is a shareholder in Advanced Life Bio, a US-based serum manufacturer, and a founding shareholder in Astrea Farinhas E Oleos S/A, a poultry by-products processor based in Brazil. His extensive experience and commitment to the biologics industry have made him a respected figure in the field.

Randal
Fitzgerald

CEO

Randal Fitzgerald is the CEO of New Life Biologics, responsible for strategy and the day-to-day operations. Randal also manages quality control, regulatory initiatives, and technical sales. With over 30 years of experience in developing technologies for various industries, including diagnostics, medical devices, pharmaceuticals, biopharmaceuticals, and agriculture from animal by-products, Randal has a strong track record. He previously served as the COO of Proliant Biologicals and led product development for Fortune 500 companies.

His expertise extends to building international facilities, negotiating with authorities, and managing operations. He is skilled in centrifugal separation, filtration, pharmaceutical systems, and more. Randal has also contributed to industry associations, serving as Vice Chair and a board member of the International Serum Industry Association and being a member of the International Society of Pharmaceutical Engineers for 25 years.